Company
Headquarters: Zhangzhou, China
Employees: 2,526
CN¥120.14 Billion
CNY as of July 1, 2025
US$16.77 Billion
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Roche | $260.54 B |
| Novartis | $243.50 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. The company's products include medicines and health products, cosmetics, daily chemicals, medical apparatus and instruments, and health foods. The company is based in Zhangzhou, China. Zhangzhou Pientzehuang Pharmaceutical., Ltd is a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥10.76 B |
| EBITDA | CN¥3.60 B |
| Gross Profit TTM | CN¥4.52 B |
| Profit Margin | 27.91% |
| Operating Margin | 36.85% |
| Quarterly Revenue Growth | -0.90% |
Zhangzhou Pientzehuang Pharmaceutical. Ltd has the following listings and related stock indices.
Stock: SSE: 600436 wb_incandescent